These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16789416)

  • 1. [Examination of the increased speed of detection of HER-2/neu gene amplification in breast cancer by fluorescence in situ hybridization (FISH) using image analysis software].
    Kuroso K; Murakami S; Jinnai M; Ueda Y
    Rinsho Byori; 2006 May; 54(5):463-5. PubMed ID: 16789416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.
    Lehr HA; Jacobs TW; Yaziji H; Schnitt SJ; Gown AM
    Am J Clin Pathol; 2001 Jun; 115(6):814-22. PubMed ID: 11392876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F; Shen T; Prichard JW
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization.
    Isola J; Tanner M; Forsyth A; Cooke TG; Watters AD; Bartlett JM
    Clin Cancer Res; 2004 Jul; 10(14):4793-8. PubMed ID: 15269154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis.
    Merola R; Mottolese M; Orlandi G; Vico E; Cognetti F; Sperduti I; Fabi A; Vitelli G; Cianciulli AM
    Eur J Cancer; 2006 Jul; 42(10):1501-6. PubMed ID: 16762541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard.
    Wang S; Saboorian MH; Frenkel EP; Haley BB; Siddiqui MT; Gokaslan S; Wians FH; Hynan L; Ashfaq R
    Am J Clin Pathol; 2001 Oct; 116(4):495-503. PubMed ID: 11601134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
    Giltnane JM; Murren JR; Rimm DL; King BL
    Histopathology; 2006 Aug; 49(2):161-9. PubMed ID: 16879393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique.
    Nathanson DR; Nash GM; Chen B; Gerald W; Paty PB
    J Am Coll Surg; 2003 Sep; 197(3):419-25. PubMed ID: 12946797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray.
    Shin SJ; Hyjek E; Early E; Knowles DM
    Int J Surg Pathol; 2006 Oct; 14(4):279-84. PubMed ID: 17041191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer.
    Skaland I; Øvestad I; Janssen EA; Klos J; Kjellevold KH; Helliesen T; Baak JP
    J Clin Pathol; 2008 Jan; 61(1):68-71. PubMed ID: 17412872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practice.
    Ma Y; Lespagnard L; Durbecq V; Paesmans M; Desmedt C; Gomez-Galdon M; Veys I; Cardoso F; Sotiriou C; Di Leo A; Piccart MJ; Larsimont D
    Clin Cancer Res; 2005 Jun; 11(12):4393-9. PubMed ID: 15958623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals.
    Konsti J; Lundin J; Jumppanen M; Lundin M; Viitanen A; Isola J
    J Clin Pathol; 2008 Mar; 61(3):278-82. PubMed ID: 17693574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy.
    Bloom K; Harrington D
    Am J Clin Pathol; 2004 May; 121(5):620-30. PubMed ID: 15151201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu analysis in breast cancer bone metastases.
    Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
    J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
    Narath R; Lörch T; Rudas M; Ambros PF
    Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization.
    Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hirano M; Hayashida K; Mizumukai E; Nanaura H; Honda N
    Oncol Rep; 2007 Nov; 18(5):1183-7. PubMed ID: 17914570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study.
    Bianco MK; Vasef MA
    Diagn Mol Pathol; 2006 Sep; 15(3):131-5. PubMed ID: 16932067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers: three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals.
    Itoh H; Miyajima Y; Umemura S; Osamura RY
    Cancer; 2008 Apr; 114(2):134-40. PubMed ID: 18306351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization.
    Rossi E; Villanacci V; Bassotti G; Casa DD; Missale G; Minelli L; Cestari R
    Diagn Mol Pathol; 2006 Sep; 15(3):125-30. PubMed ID: 16932066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer.
    Purnomosari D; Aryandono T; Setiaji K; Nugraha SB; Pals G; van Diest PJ
    Biotech Histochem; 2006; 81(2-3):79-85. PubMed ID: 16908432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.